Laura Luberto

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer

L. Fattore, R. Mancini, D. Malpicci, 2013, Oncotarget.

Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors

R. Mancini, G. Ciliberto, M. Alimandi, 2012, Journal of cellular physiology.

Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer

D. Eberli, C. Poyet, Irina Banzola, 2017, Oncotarget.

Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy

B. Pagano, E. Pich, A. Anastasi, 2021, bioRxiv.

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery

M. Bolognesi, C. Camilloni, E. Pich, 2022, bioRxiv.

Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections

G. Salvatori, G. Roscilli, E. Fiscarelli, 2021, Frontiers in Microbiology.

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

G. Ciliberto, M. Fanciulli, F. Palombo, 2019, Journal of Experimental & Clinical Cancer Research.

Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.

R. Mancini, G. Ciliberto, N. La Monica, 2015, Human gene therapy.